Home Cart Sign in  
Chemical Structure| 574-84-5 Chemical Structure| 574-84-5

Structure of Fraxetin
CAS No.: 574-84-5

Chemical Structure| 574-84-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fraxetin, a natural product isolated and purified from the bark of Fraxinus brngeana DC., has protective against rotenone-induced cytotoxicity, apoptotic death and antioxidant activities.

Synonyms: 7,8-Dihydroxy-6-Methoxycoumarin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fraxetin

CAS No. :574-84-5
Formula : C10H8O5
M.W : 208.17
SMILES Code : O=C1C=CC2=C(O1)C(O)=C(O)C(OC)=C2
Synonyms :
7,8-Dihydroxy-6-Methoxycoumarin
MDL No. :MFCD00006873
InChI Key :HAVWRBANWNTOJX-UHFFFAOYSA-N
Pubchem ID :5273569

Safety of Fraxetin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302+H312+H332-H315-H319-H335
Precautionary Statements:P261-P280-P305+P351+P338

Related Pathways of Fraxetin

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Yeast microsomes 100 μM fraxetin 1 hour Validate CYP82C4's ability to convert fraxetin to sideretin Nat Chem Biol. 2018 May;14(5):442-450
Patu8988 cells 50 or 100 μM 24 hours To evaluate the effect of Fraxetin on the proliferation of Patu8988 cells. Results showed that Fraxetin inhibited the proliferation of Patu8988 cells in a concentration-dependent manner. Aging (Albany NY). 2021 Jul 28;13(14):18545-18563
PANC-1 cells 50 or 100 μM 24 hours To evaluate the effect of Fraxetin on the proliferation of PANC-1 cells. Results showed that Fraxetin inhibited the proliferation of PANC-1 cells in a concentration-dependent manner. Aging (Albany NY). 2021 Jul 28;13(14):18545-18563
prostate cancer cell DU145 10, 20, 40 μM 48 hours To evaluate the effect of Fraxetin on cell migration and invasion, results showed that Fraxetin significantly inhibited DU145 cell migration and invasion Bioengineered. 2022 Apr;13(4):9345-9356
prostate cancer cell DU145 10, 20, 40 μM 48 hours To evaluate the effect of Fraxetin on cell apoptosis, results showed that Fraxetin significantly increased the ratio of apoptotic DU145 cells Bioengineered. 2022 Apr;13(4):9345-9356
prostate cancer cell DU145 10, 20, 40 μM 24, 48, 72 hours To evaluate the effect of Fraxetin on cell proliferation, results showed that Fraxetin significantly inhibited DU145 cell proliferation Bioengineered. 2022 Apr;13(4):9345-9356
prostate cancer cell DU145 10, 20, 40, 80 μM 48 hours To evaluate the effect of Fraxetin on cell viability, results showed that Fraxetin significantly reduced DU145 cell viability Bioengineered. 2022 Apr;13(4):9345-9356
prostatic epithelial cell RWPE-1 10, 20, 40, 80 μM 48 hours To evaluate the effect of Fraxetin on cell viability, results showed that Fraxetin had no obvious effect on RWPE-1 cell viability Bioengineered. 2022 Apr;13(4):9345-9356
HL-60 cells 0, 20, 40, 80, 160 µM 24, 48, 72 hours To evaluate the inhibitory effect of Fraxetin on the proliferation of HL-60 cells. The results showed that the viability of HL-60 cells was inhibited at different time points as the concentration of fraxetin increased. BMC Complement Med Ther. 2024 Jun 10;24(1):226
THP-1 cells 0, 20, 40, 80, 160 µM 24, 48, 72 hours To evaluate the inhibitory effect of Fraxetin on the proliferation of THP-1 cells. The results showed that the viability of THP-1 cells was inhibited at different time points as the concentration of fraxetin increased. BMC Complement Med Ther. 2024 Jun 10;24(1):226
3T3-L1 cells 0, 5, 10, 20, 50, 100 µM 2 days To evaluate the effect of Fraxetin on adipogenesis and lipid accumulation. Results showed that Fraxetin significantly inhibited lipid droplet accumulation in 3T3-L1 cells without cytotoxicity. Antioxidants (Basel). 2022 Sep 24;11(10):1893
HL-60 cells 40 µM, 80 µM, 120 µM 48 hours To evaluate the apoptotic effect of Fraxetin on HL-60 cells. The results showed that the apoptosis rate of HL-60 cells gradually increased with increasing concentrations of fraxetin. BMC Complement Med Ther. 2024 Jun 10;24(1):226
THP-1 cells 50 µM, 100 µM, 150 µM 48 hours To evaluate the apoptotic effect of Fraxetin on THP-1 cells. The results showed that the apoptosis rate of THP-1 cells gradually increased with increasing concentrations of fraxetin. BMC Complement Med Ther. 2024 Jun 10;24(1):226

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice (BALB/c) Pancreatic ductal adenocarcinoma (PDA) xenograft model Intragastric administration 25 mg/kg·d Every 3 days for one month To evaluate the effect of Fraxetin on tumor growth and metastasis in PDA xenograft models. Results showed that Fraxetin significantly inhibited tumor growth and metastasis. Aging (Albany NY). 2021 Jul 28;13(14):18545-18563
Arabidopsis thaliana Fe-deficient Arabidopsis Media supplementation 120 μM fraxetin 14 days Partially rescued the s8h mutants, indicating that fraxetin is a bioactive compound participating in the acquisition of Fe from immobile sources. Plant Physiol. 2018 May;177(1):194-207
Arabidopsis thaliana F6’h1, s8h, cyp82C4 mutants Agar medium 150 μM 6-hour treatment, lasting 7 days Validate the rescue effect of fraxetin and sideretin on iron deficiency phenotypes Nat Chem Biol. 2018 May;14(5):442-450

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.80mL

0.96mL

0.48mL

24.02mL

4.80mL

2.40mL

48.04mL

9.61mL

4.80mL

References

 

Historical Records

Categories